REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bayer Sp. z o.o. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bayer Sp. z o.o. Profile Updated: January 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Bayer Sp. z o.o. represents on Polish market companies that belong to Bayer AG concern. The most important are: Wolff Cellulosics (foils from artificial materials and nutritive foils), H.C. Starck GmbH & Co. KG (metal powders), Rhein Chemie Rheinau GmbH (special chemistry), Hennecke GmbH (installations for chemical industry), Kerr Mc Gee Pigments International GmbH, Epurex Films GmbH & Co KG (foils).

Headquarters
Ul. Al. Jerozolimskie 158
Warsaw; Mazowieckie; Postal Code: 02-326

Contact Details: Purchase the Bayer Sp. z o.o. report to view the information.

Website: http://www.bayer.com.pl

Basic Information
Total Employees:
Purchase the Bayer Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Bayer Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bayer Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Bayer Sp. z o.o. report to view the information.
Incorporation Date:
August 14, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
"Monsanto Polska" Sp. z o.o.
64.12%
Company Performance
Financial values in the chart are available after Bayer Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
14.4%▲
Total operating revenue
14.13%▲
Operating profit (EBIT)
24.91%▲
EBITDA
18.59%▲
Net Profit (Loss) for the Period
15.43%▲
Total assets
21.83%▲
Total equity
16.13%▲
Operating Profit Margin (ROS)
0.35%▲
Net Profit Margin
0.03%▲
Return on Equity (ROE)
-0.08%▼
Quick Ratio
-0.32%▼
Cash Ratio
-0.01%▼

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
"Roche Polska" Sp. z o.o.
Lek S.A.
 
Teva Operations Poland Sp. z o.o.
Adamed Pharma S.A.
 
Delpharm Poznan S.A.
Centrala Farmaceutyczna "Cefarm" S.A.
 
Sanofi-Aventis Sp. z o.o.
Aflofarm Farmacja Polska Sp. z o.o.
 
"Usp Zdrowie" Sp. z o.o.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo